<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3167">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01905501</url>
  </required_header>
  <id_info>
    <org_study_id>Versione 02.01.2013</org_study_id>
    <nct_id>NCT01905501</nct_id>
  </id_info>
  <brief_title>Sevoflurane Protective Effect on Ischemia-reperfusion Injury. Multicenter, Randomized Controlled Trial</brief_title>
  <official_title>Sevoflurane Protective Effect on Ischemia-reperfusion Injury in Patients Undergoing Reconstructive Plastic Surgery  With  Microsurgical Flap. Multicenter, Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Regina Elena Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Regina Elena Cancer Institute</source>
  <oversight_info>
    <authority>Italy: Ethics Committee</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to evaluate the possible protective effect of anesthetic technique
      balanced(with sevoflurane) compared with total intravenous anesthetic technique
      (propofol,remifentanil). The hypothesis is that the Sevoflurane may exert protective effect
      in regard to the ischemia-reperfusion injury induced on the microsurgical breast free flap
      during transfer to receiving area. The investigators will evaluate the continuous flap
      tissue oximetry and the level of biochemical markers.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>continuous tissue oximetry (NIRS)</measure>
    <time_frame>20 hours</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Biochemical Markers</measure>
    <time_frame>Preoperative and 24 hours post operative</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lactate Clearance</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">132</enrollment>
  <condition>Microsurgical Free Flaps</condition>
  <arm_group>
    <arm_group_label>Total intravenous anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Total intravenous anaesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Balanced anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Balanced anesthesia</intervention_name>
    <description>Et-Sevo maIntained 1,8-2%, remifentanyl according  target-controlled infusion maintained 1-3 ng/ml</description>
    <arm_group_label>Balanced anesthesia</arm_group_label>
    <other_name>Inhalation anesthesia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Total intravenous anesthesia</intervention_name>
    <description>Propofol  3-4 Âµg/ml and remifentanyl 1-3 ng/ml according target-controlled infusion</description>
    <arm_group_label>Total intravenous anesthesia</arm_group_label>
    <other_name>TIVA-TCI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patient selected for plastic breast surgery With microsurgical Free flap Over 18 y Asa
        I/II

        Exclusion Criteria:

        Unusual reaction to anesthetic drugs Suspect for malignant hyperthermia Vasculopathic
        disease Coagulation disease
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ester Forastiere, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Regina Elena CI</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ester Forastiere</last_name>
    <email>forastiere@ifo.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Regina Elena CI</name>
      <address>
        <city>Rome</city>
        <zip>00144</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ester Forastiere, M.D.</last_name>
      <email>forastiere@ifo.it</email>
    </contact>
    <investigator>
      <last_name>Ester Forastiere, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 22, 2013</lastchanged_date>
  <firstreceived_date>July 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Regina Elena Cancer Institute</investigator_affiliation>
    <investigator_full_name>Ester Forastiere</investigator_full_name>
    <investigator_title>M.D., Chief of Critical Area Department</investigator_title>
  </responsible_party>
  <keyword>Balanced anesthesia</keyword>
  <keyword>Inhalation anesthesia</keyword>
  <keyword>Reperfusion injury</keyword>
  <keyword>Microsurgical Free flap</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Reperfusion Injury</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
